Details about Anirban Basu

Access statistics for papers by Anirban Basu.

Last updated 2022-10-26. Update your information in the RePEc Author Service.

Short-id: pba977

Working Papers

2025

1. The Role of Physician Altruism in the Physician-Industry Relationship: Evidence from Linking Experimental and Observational Data
   NBER Working Papers, National Bureau of Economic Research, Inc

2024

2. Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California
   NBER Working Papers, National Bureau of Economic Research, Inc
3. Dynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies
   NBER Working Papers, National Bureau of Economic Research, Inc

2023

4. Hidden Figures: Uncovering Quantities Behind Zeros with Econometrics
   NBER Working Papers, National Bureau of Economic Research, Inc

2021

5. Understanding Algorithmic Discrimination in Health Economics Through the Lens of Measurement Errors
   NBER Working Papers, National Bureau of Economic Research, Inc

2019

6. Impact of Rural and Urban Hospital Closures on Inpatient Mortality
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (23)

2018

7. The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices
   NBER Working Papers, National Bureau of Economic Research, Inc

2017

8. Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (12)
9. Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion
   NBER Working Papers, National Bureau of Economic Research, Inc
10. Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (2)

2016

11. Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)

2014

12. Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State
    NBER Working Papers, National Bureau of Economic Research, Inc
13. The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (10)
14. Welfare Implications of Learning Through Solicitation versus Diversification in Health Care
    NBER Working Papers, National Bureau of Economic Research, Inc
    See also Journal Article Welfare implications of learning through solicitation versus diversification in health care, Journal of Health Economics, Elsevier (2015) View citations (1) (2015)

2012

15. Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)

2011

16. Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (18)
    See also Journal Article Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care, Journal of Health Economics, Elsevier (2011) View citations (18) (2011)
17. Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality
    Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York View citations (2)
    Also in Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York (2011) View citations (2)

2010

18. The Impact of Comparative Effectiveness Research on Health and Health Care Spending
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (11)
    See also Journal Article The impact of comparative effectiveness research on health and health care spending, Journal of Health Economics, Elsevier (2011) View citations (13) (2011)

2009

19. Estimating Lifetime or Episode-of-illness Costs
    Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York

2008

20. The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures
    NBER Working Papers, National Bureau of Economic Research, Inc
21. Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (6)
    Also in Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York (2008) View citations (6)

2007

22. Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients
    Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York View citations (70)

2003

23. Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data
    NBER Technical Working Papers, National Bureau of Economic Research, Inc View citations (5)
    Also in Working Papers, Harris School of Public Policy Studies, University of Chicago (2003)
    See also Journal Article Generalized modeling approaches to risk adjustment of skewed outcomes data, Journal of Health Economics, Elsevier (2005) View citations (132) (2005)

Journal Articles

2017

1. Measuring the Value of Pharmaceuticals in the US Health System
   PharmacoEconomics, 2017, 35, (1), 1-4

2015

2. Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables
   Stata Journal, 2015, 15, (2), 397-410 View citations (2)
3. Welfare implications of learning through solicitation versus diversification in health care
   Journal of Health Economics, 2015, 42, (C), 165-173 View citations (1)
   See also Working Paper Welfare Implications of Learning Through Solicitation versus Diversification in Health Care, NBER Working Papers (2014) (2014)

2014

4. CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS?
   Health Economics, 2014, 23, (4), 462-472 View citations (2)
5. ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS
   Journal of Applied Econometrics, 2014, 29, (4), 671-691 View citations (14)
6. HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH
   Health Economics, 2014, 23, (3), 359-373 View citations (6)
7. RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION”
   Health Economics, 2014, 23, (3), 376-378

2013

8. HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE
   Health Economics, 2013, 22, (9), 1052-1070 View citations (113)
9. Personalized Medicine in the Context of Comparative Effectiveness Research
   Forum for Health Economics & Policy, 2013, 16, (2), S73-S86 View citations (1)

2012

10. Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials
    PharmacoEconomics, 2012, 30, (10), 859-868

2011

11. Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care
    Journal of Health Economics, 2011, 30, (3), 549-559 View citations (18)
    See also Working Paper Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care, NBER Working Papers (2011) View citations (18) (2011)
12. Erratum: Estimating lifetime or episode‐of‐illness costs under censoring
    Health Economics, 2011, 20, (1), 125-126 View citations (1)
13. The impact of comparative effectiveness research on health and health care spending
    Journal of Health Economics, 2011, 30, (4), 695-706 View citations (13)
    See also Working Paper The Impact of Comparative Effectiveness Research on Health and Health Care Spending, NBER Working Papers (2010) View citations (11) (2010)

2010

14. Estimating lifetime or episode‐of‐illness costs under censoring
    Health Economics, 2010, 19, (9), 1010-1028 View citations (6)

2008

15. Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling
    Journal of Health Economics, 2008, 27, (3), 531-543 View citations (623)

2006

16. Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity
    Health Economics, 2006, 15, (10), 1091-1107 View citations (16)

2005

17. Extended generalized linear models: Simultaneous estimation of flexible link and variance functions
    Stata Journal, 2005, 5, (4), 501-516 View citations (6)
18. Generalized modeling approaches to risk adjustment of skewed outcomes data
    Journal of Health Economics, 2005, 24, (3), 465-488 View citations (132)
    See also Working Paper Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data, NBER Technical Working Papers (2003) View citations (5) (2003)
19. Implications of spillover effects within the family for medical cost-effectiveness analysis
    Journal of Health Economics, 2005, 24, (4), 751-773 View citations (36)

2004

20. Comparing alternative models: log vs Cox proportional hazard?
    Health Economics, 2004, 13, (8), 749-765 View citations (37)

2002

21. Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients?
    RAND Journal of Economics, 2002, 33, (3), 447-468 View citations (29)

Software Items

2014

1. IVCHECK: Stata module to choose between OLS and contaminated IV
   Statistical Software Components, Boston College Department of Economics